CCL24 (Nebokitug Biosimilar) Recombinant Monoclonal Antibody

Code: CSB-RA004788MB1HU
Size:
100ug
100ug500ug1mg5mg10mg50mg100mg200mg
US$199
Quantity:
Species Reactivity: Human
For inquiries on large quantities or another requirements
Send an Inquiry
Start an on-line Chat
Online ordering is currently available for U.S. customers only. For orders outside the U.S., please kindly submit an inquiry or start a chat with us.

Product Details

Uniprot NO.
Alternative Names
CM101 research-grade biosimilar; CM101 (Chemomab) research-grade biosimilar; CM 101 (Chemomab) research-grade biosimilar ;CCL24 antibody; MPIF2 antibody; SCYA24 antibody; C-C motif chemokine 24 antibody; CK-beta-6 antibody; Eosinophil chemotactic protein 2 antibody; Eotaxin-2 antibody; Myeloid progenitor inhibitory factor 2 antibody; MPIF-2 antibody; Small-inducible cytokine A24 antibody
Species Reactivity
Human
Immunogen
Recombinant Human CCL24 protein
Conjugate
Non-conjugated
Clonality
Monoclonal
Buffer
0.01M PBS,pH7.4
Storage
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Notes
Validation Status
Application-specific performance (e.g., in flow cytometry, ELISA, IHC or other assay formats) has not yet been experimentally verified by CUSABIO. Users are advised to determine the optimal working conditions empirically in their own assay systems.
Guaranteed Quality
① Antibody purity > 95% tested by SDS-PAGE.
② Endotoxin level < 0.1EU/ug tested by LAL method.
Lead Time
3-4 weeks
Note: All of our proteins are default shipped with normal blue ice packs, if you request to ship with dry ice, please communicate with us in advance and extra fees will be charged.
Concentration
It differs from different batches. Please contact us to confirm it.
Usage
It is a non-therapeutic biosimilar antibody, owning the same variable region from the corresponding approved therapeutic antibody. In conclusion, it is a research-grade biosimilar antibody and expressed in mammalian cell, which can be directly used as positive controls in drug discovery or used for rapid verification of the biological functions of target protein.
Datasheet & COA
Description

This recombinant monoclonal antibody is developed as a research-grade biosimilar to Nebokitug, targeting CCL24 (also known as eotaxin-2), a CC chemokine family member that plays a critical role in eosinophil recruitment and activation. CCL24 binds primarily to the CCR3 receptor and mediates inflammatory responses by attracting eosinophils to sites of allergic inflammation. This chemokine is implicated in various eosinophil-associated disorders, including asthma, atopic dermatitis, allergic rhinitis, and eosinophilic esophagitis, where elevated CCL24 levels correlate with disease severity and tissue eosinophilia.

Nebokitug represents a therapeutic antibody designed to neutralize CCL24 activity, thereby reducing eosinophil-mediated inflammation in allergic and inflammatory conditions. This biosimilar antibody provides researchers with a valuable tool for investigating CCL24-dependent mechanisms in allergic diseases, studying eosinophil biology, and exploring therapeutic interventions targeting the CCL24-CCR3 axis. The antibody enables detailed examination of chemokine signaling pathways and their contribution to inflammatory pathologies in preclinical research models.

Customer Reviews and Q&A

 Customer Reviews

Target Background

Function(From Uniprot)
Chemotactic for resting T-lymphocytes, and eosinophils. Has lower chemotactic activity for neutrophils but none for monocytes and activated lymphocytes. Is a strong suppressor of colony formation by a multipotential hematopoietic progenitor cell line. Binds to CCR3.
Gene References into Functions
  1. Study showed that CCL24 was upregulated in hepatocellular carcinoma (HCC) tissues and correlated with poor prognosis in HCC patients . Also, CCL24 was associated with the metastatic potential of HCC cell lines and promoted proliferation, migration, and invasion. PMID:28042950
  2. Mean eotaxin 2 concentrations in nasal fluid in patients with perennial allergic rhinitis and nonallergic and allergic chronic rhinosinusitis with nasal polyps patients were significantly higher in comparison to control subjects. PMID:28587510
  3. HMGB1 did not elicit chemotaxis of human eosinophils alone and had no effect in combination with the eosinophil chemotactic agent, eotaxin-2 (CCL24). PMID:25774667
  4. these data suggest that CCL26 and CCL24 are likely involved in the pathogenesis of chronic nasal hypereosinophilia, with a complex cooperation and different involvement of the various members of eotaxin family. PMID:24989688
  5. Pregnancy associated environments increased local CCL24/CCR3, supporting the process of decidualization in human early pregnancy. PMID:23696919
  6. Phosphodiesterase 4 inhibitors, rolipram and RO-20-1724 have no effect on CCL24 expression in human primary bronchial epithelial cells. PMID:22946025
  7. Study shows that CCL24 levels were significantly increased in age-related macular degeneration (AMD) patients despite Avastin treatment as compared with normal controls and those without Avastin. PMID:23025269
  8. CCR3 is differentially expressed on inflammatory cells in rheumatoid arthritis, while eotaxin-2, a potent CCR3 agonist, is differentially expressed in active disease. PMID:20659406
  9. stimulates lung fibroblast proliferation and collagen synthesis PMID:20143648
  10. alters eosinophil integrin function via mitogen-activated protein kinases PMID:12034562
  11. Intradermal injection of CCL24 induces recruitment of eosinophils, basophils, neutrophils, and macrophages as well as features of early- and late-phase allergic reactions in atopic and nonatopic volunteers. PMID:12193745
  12. Plasma eotaxin-2 concentrations differed in asthmatic patients with respect to aspirin intolerance and tolerance, indicating that eotaxin-2 may be differentially up-regulated according to aspirin intolerance. PMID:16304252
  13. Our results suggest that Eo2 +179T>C and Eo2 +275C>T of eotaxin-2 might be associated with the susceptibility of ulcerative colitis. PMID:16391516
  14. These data support the idea that CCL24/eotaxin-2 is part of the mechanism of CD4 lymphocyte activation paracrinally induced by Nef. PMID:17630924
  15. eotaxin-2 is a chemokine strongly associated with primary and metastatic tumors of colorectal origin PMID:17908961
  16. the ability to produce eotaxin-2/CCL24 is acquired during the differentiation into eosinophilic lineage which is dependent on GATA-1 expression PMID:17917245
  17. This protein is an eosinophil chemoattractant that is up-regulated by human rhinovirus infection in cultured bronchial epithelial cells. PMID:11467997

Show More

Hide All

Subcellular Location
Secreted.
Protein Families
Intercrine beta (chemokine CC) family
Tissue Specificity
Activated monocytes and activated T lymphocytes.
Database Links

HGNC: 10623

UNIGENE: Hs.247838

KEGG: hsa:6369

STRING: 9606.ENSP00000222902

OMIM: 602495

icon of phone
Call us
301-363-4651 (Available 9 a.m. to 5 p.m. CST from Monday to Friday)
icon of address
Address
No. 269, Shendun 5th Road, Donghu Hi-Tech Development Area, Hubei Province, 430206, P.R.China
icon of social media
Join us with

Subscribe newsletter

Leave a message

* To protect against spam, please pass the CAPTCHA test below.
CAPTCHA verification
© 2007-2025 CUSABIO TECHNOLOGY LLC All rights reserved. 鄂ICP备15011166号-1
Select 0 Products